Literature DB >> 12534945

Bacterial otitis media: current vaccine development strategies.

Allan W Cripps1, Jennelle Kyd.   

Abstract

Otitis media is the most common reason for children less than 5 years of age to visit a medical practitioner. Whilst the disease rarely results in death, there is significant associated morbidity. The most common complication is loss of hearing at a critical stage of the development of speech, language and cognitive abilities in children. The cause and pathogenesis of otitis media is multifactorial. Among the contributing factors, the single most important are viral and bacterial infections. Infection with respiratory syncytial virus, influenza viruses, para-influenza viruses, enteroviruses and adenovirus are most commonly associated with acute and chronic otitis media. Streptococcus pneumoniae, non-typeable Haemophilus influenzae and Moraxella catarrhalis are the most commonly isolated bacteria from the middle ears of children with otitis media. Treatment of otitis media has largely relied on the administration of antimicrobials and surgical intervention. However, attention has recently focused on the development of a vaccine. For a vaccine to be effective against bacterial otitis media, it must, at the very least, contain antigens that induce a protective immune response in the middle ear against the three most common infecting bacteria. Whilst over the past decade there has been significant progress in the development of vaccines against invasive S. pneumoniae disease, these vaccines are less efficacious for otitis media. The search for candidate vaccine antigens for non-typeable H. influenzae are well advanced whilst less progress has been made for M. catarrhalis. No human studies have been conducted for non-typeable H. influenzae or M. catarrhalis and the concept of a tribacterial vaccine remains to be tested in animal models. Only when vaccine antigens are determined and an understanding of the immune responses induced in the middle ear by infection and immunization is gained will the formulation of a tribacterial vaccine against otitis media be possible.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534945     DOI: 10.1046/j.0818-9641.2002.01141.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  11 in total

1.  Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20.

Authors:  Alistair Harrison; David W Dyer; Allison Gillaspy; William C Ray; Rachna Mungur; Matthew B Carson; Huachun Zhong; Jenny Gipson; Mandy Gipson; Linda S Johnson; Lisa Lewis; Lauren O Bakaletz; Robert S Munson
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

Review 3.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

4.  Association of IS1016 with the hia adhesin gene and biotypes V and I in invasive nontypeable Haemophilus influenzae.

Authors:  Sarah W Satola; Brooke Napier; Monica M Farley
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

5.  Possible high rate of transmission of nontypeable Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, between children and their parents.

Authors:  Hiroshi Watanabe; Kazuhiko Hoshino; Rinya Sugita; Norichika Asoh; Kiwao Watanabe; Kazunori Oishi; Tsuyoshi Nagatake
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

6.  Genetically Diversity of Pseudomonas aeruginosa Isolated from Chronic Suppurative Otitis Media with Respect to Their Antibiotic Sensitivity Pattern.

Authors:  Mahesh Chandra Sahu; Santosh Kumar Swain; Subrat Kumar Kar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-13

7.  Antimicrobial susceptibility patterns of bacteria isolated from patients with ear discharge in Jimma Town, Southwest, Ethiopia.

Authors:  Kasahun Gorems; Getenet Beyene; Melkamu Berhane; Zeleke Mekonnen
Journal:  BMC Ear Nose Throat Disord       Date:  2018-12-04

8.  Bacterial profile and antimicrobial susceptibility patterns of otitis media in Ayder Teaching and Referral Hospital, Mekelle University, Northern Ethiopia.

Authors:  Araya Gebereyesus Wasihun; Yilikal Zemene
Journal:  Springerplus       Date:  2015-11-14

Review 9.  Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.

Authors:  Chinh C Ngo; Helen M Massa; Ruth B Thornton; Allan W Cripps
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

10.  Otitis media: viruses, bacteria, biofilms and vaccines.

Authors:  Helen M Massa; Allan W Cripps; Deborah Lehmann
Journal:  Med J Aust       Date:  2009-11-02       Impact factor: 7.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.